Assignee
LICENTIA LTD
FI·17 granted patents·22 pending applications·414 citations·filing 1997–2009
Top patents by PatentIndex Score
39 records- 0194US6361946B1Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofLICENTIA LTD·Filed 1998·Granted Mar 26, 2002·149 cites·37 claims
- 0293US6818220B1Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereofLICENTIA LTD·Filed 2000·Granted Nov 16, 2004·40 cites·27 claims
- 0388US6794144B1Methods and materials for generating SH3 domains with tailored binding propertiesLICENTIA LTD·Filed 2000·Granted Sep 21, 2004·64 cites·6 claims
- 0487US7105481B2Method for stimulating connective tissue growth or wound healingLICENTIA LTD·Filed 2002·Granted Sep 12, 2006·16 cites·8 claims
- 0586US7309604B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsLICENTIA LTD·Filed 2005·Granted Dec 18, 2007·7 cites·86 claims
- 0684US6824777B1Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyLICENTIA LTD·Filed 1998·Granted Nov 30, 2004·57 cites·54 claims
- 0782US8029984B2Materials and methods for colorectal cancer screening, diagnosis and therapyLICENTIA LTD·Filed 2004·Granted Oct 4, 2011·33 cites·22 claims
- 0876US7452969B2Neurotrophic factor protein and uses thereofLICENTIA LTD·Filed 2003·Granted Nov 18, 2008·9 cites·2 claims
- 0973US7148037B2Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2002·Granted Dec 12, 2006·4 cites·12 claims
- 1069US7355022B2Gene functionally related to dyslexiaLICENTIA LTD·Filed 2003·Granted Apr 8, 2008·5 cites·7 claims
- 1166US2008145366A1Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useLICENTIA LTD·Filed 2007·Application pending·0 cites
- 1261US6515105B1Neuropilin/growth factor complexes and uses thereofLICENTIA LTD·Filed 1999·Granted Feb 4, 2003·15 cites·6 claims
- 1358US2007042413A1Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 1457US7572616B2Alternative oxidase and uses thereofLICENTIA LTD·Filed 2006·Granted Aug 11, 2009·1 cites·27 claims
- 1557US2010159458A1Method for predicting the response to a therapyLICENTIA LTD·Filed 2007·Application pending·0 cites
- 1657US2007082848A1VEGF-C or VEGF-D materials and methods for treatment of neuropathologiesLICENTIA LTD·Filed 2006·Application pending·0 cites
- 1756US6696259B1Assays using glial cell line-derived neurotrophic factor receptorsLICENTIA LTD·Filed 1997·Granted Feb 24, 2004·10 cites·2 claims
- 1855US2010285045A1Novel Neurotrophic Factor Protein and Uses ThereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 1955US2008241178A1Novel human gene functionally related to dyslexiaLICENTIA LTD·Filed 2008·Application pending·0 cites
- 2054US2010279281A1Method of identifying lung cancers associated with asbestos-exposureLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2154US2011212091A1Materials and methods for inhibiting cancer cell invasionLICENTIA LTD·Filed 2009·Application pending·0 cites
- 2253US2008241142A1Neuropilin/VEGF-C/VEGFR-3 Materials and MethodsLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2352US2008241818A1Method and microarray for detecting herpesvirusesLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2449US2008147045A1Use of VEGF-C or VEGF-D in Reconstructive SurgeryLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2549US2006195915A1Novel neurotrophic factor protein and uses thereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 2648US2008312141A1Peptide ligands for prostate specific antigenLICENTIA LTD·Filed 2008·Application pending·0 cites
- 2747US2009214496A1Bmx/etk tyrosine kinase gene therapy materials and methodsLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2843US2006085149A1Method and apparatus for computation of electrostatic potentialLICENTIA LTD·Filed 2005·Application pending·0 cites
- 2943US2009156611A1Mammalian hedgehog signaling modulatorsLICENTIA LTD·Filed 2006·Application pending·0 cites
- 3041US2006025338A1Compositions and methods for treatment of lymphatic and venous vessel arterializationLICENTIA LTD·Filed 2005·Application pending·0 cites
- 3141US2005282233A1Multivalent antibody materials and methods for VEGF/PDGF family of growth factorsLICENTIA LTD·Filed 2005·Application pending·0 cites
- 3240US2011123572A1Activated fibroblasts for treating tissue and/or organ damageLICENTIA LTD·Filed 2007·Application pending·0 cites
- 3339US2006258576A1Gdnf-related neuropeptidesLICENTIA LTD·Filed 2004·Application pending·0 cites
- 3438US2008241168A1Transmembrane protein amigo and uses thereofLICENTIA LTD·Filed 2008·Application pending·0 cites
- 3536US7414023B2Peptide ligands for prostate specific antigenLICENTIA LTD·Filed 2001·Granted Aug 19, 2008·0 cites·9 claims
- 3636US2007280947A1Tie Receptor and Tie Ligand Materials and Methods for Modulating Female FertilityLICENTIA LTD·Filed 2005·Application pending·0 cites
- 3734US7488588B1Compounds related to or derived from GFR α4 and their useLICENTIA LTD·Filed 2000·Granted Feb 10, 2009·0 cites·12 claims
- 3824US6458929B1Myotilin, a novel actin-organizing proteinLICENTIA LTD·Filed 1999·Granted Oct 1, 2002·4 cites·6 claims
- 3922US7160991B1Vascular endothelial growth factor polypeptidesLICENTIA LTD·Filed 1999·Granted Jan 9, 2007·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when LICENTIA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →